Synthesis and Antimicrobial Evaluation of Newly Synthesized N,S‐Bisphosphonate Derivatives

An easy strategy for the synthesis of tetraethyl‐2‐(3‐mercapto‐4H‐1,2,4‐triazol‐4‐ylamino)‐2‐(aryl)ethane‐1,1‐diyldiphosphonate and tetraethyl‐(6‐(aryl)‐5,6‐dihydro1,2,4]triazolo3,4‐b]‐1,3,4]thiadiazol‐6‐yl)methylenediphosphonate derivatives with reasonable 67–85% overall yields has been developed. The approach was achieved via applying Wadsworth–Horner–Emmons reagent, tetraethylmethylenebisphosphonate, to 4‐(arylideneamino)‐4H‐1,2,4‐triazole‐3‐thiols under phase‐transfer catalysis conditions. Screening results of antimicrobial potency for 12 out of 17 methylene‐1,1‐bisphosphonate products were reported. Two of the tested thiadiazolomethylenebisphosphonates displayed better spectrum of antimicrobial activity against the pathogens, compared with that of the positive controls.